HomeMarketWill Earnings Beat Estimates? 4D Molecular Therapeutics Inc. (FDMT) Stock

Will Earnings Beat Estimates? 4D Molecular Therapeutics Inc. (FDMT) Stock

H.C. Wainwright raised the price target for the 4D Molecular Therapeutics Inc. (NASDAQ:FDMT) stock to “a Buy”. The rating was released on November 18, 2022, according to finviz. We previously noted in another research note published on November 15, 2022 by Goldman that upgraded the stock from a Neutral to a Buy with a price target of $68 for FDMT stock. The research report from SVB Leerink has downgraded the stock from Outperform to Mkt Perform, with a price target set at $12. The stock was initiated by Jefferies, who disclosed in a research note on June 22, 2022, to Buy and set the price objective to $22. In their research brief published January 04, 2022, SVB Leerink analysts initiated the 4D Molecular Therapeutics Inc. stock to Outperform with a price target of $30.

The latest trade, Performances and Moving Averages give us the following Picture

The share price of 4D Molecular Therapeutics Inc. (NASDAQ:FDMT) dipped -1.02% to close Wednesday’s market session at $23.26, lower as compared to yesterday’s close. The stock price fluctuated between $22.7158 and $24.21 throughout the trading session with the volume trading being 461543 shares, which represented a significant variation when compared to the three months average volume of 490.53K shares. The firm’s stock price fluctuated 10.71% within the last five trades and 210.13% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 217.76% in the last 6 months and 170.78% was added to its value over the previous 3 months. FDMT stock is trading at a margin of 80.44%, 135.52% and 119.31% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


As of the close of trading, FDMT deals in the Healthcare domain. The stock is trading -6.28 percent below its 52-week high and 337.22 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -34.1. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does 4D Molecular Therapeutics Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $767.58 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 383.79 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 3.00, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 11.51 percent of 4D Molecular Therapeutics Inc. shares are owned by insiders, and 82.30 percent are held by financial institutions.



Please enter your comment!
Please enter your name here

Recent Post

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.